AQUA BIO TECHNOLOGY ASA: årsregnskap 2024 vs 2023
Shrank 52% on revenue, weaker earnings, cash halved-plus
approved 2025-06-25; registry 2025-09-22; journal 2025 756893
Summary
What changed
Comparing Årsregnskap 2024 with 2023 for AQUA BIO TECHNOLOGY ASA. Revenue 516.3k NOK → 247.6k NOK (-52.0%). Net result -21.02m NOK → -233.16m NOK. Equity 62.72m NOK → 6.15m NOK.
On the constructive side: owners injected capital; payroll decreased. Pressures included: revenue fell; operating result weakened; net result weakened.
Also worth watching: thin equity buffer; sharp cash drawdown; book investments changed. All figures are taken from the published annual accounts for AQUA BIO TECHNOLOGY ASA.
At a glance
Scorecard
What improved
-
↑
Owners injected capital
Paid-in equity rose 164.33m NOK → 281.52m NOK (+117.19m NOK). Reported fact
-
↑
Payroll decreased
Salary cost 8.37m NOK → 7.53m NOK (1621% → 3044% of revenue). Calculated
What deteriorated
-
↓
Revenue fell
Operating income / revenue moved from 516.3k NOK to 247.6k NOK (-52.0% YoY). Calculated
-
↓
Operating result weakened
Operating result -22.26m NOK → -62.85m NOK (op. margin -4312.1% → -25386.0%). Calculated
-
↓
Net result weakened
Net result -21.02m NOK → -233.16m NOK (net margin -4072.1% → -94183.9%). Calculated
-
↓
Equity eroded
Book equity 62.72m NOK → 6.15m NOK (equity ratio 63.0% → 4.1%). Calculated
-
↓
Cash fell
Bank deposits 1.05m NOK → 361.9k NOK (-65.5% YoY). Calculated
Things to notice
-
·
Thin equity buffer
Equity ratio is 4.1% of assets — limited loss-absorbing capacity on a stand-alone basis. Interpretation
-
·
Sharp cash drawdown
Cash fell by more than 60% YoY (1.05m NOK → 361.9k NOK). Check whether funds moved to group receivables, investments, or operating burn. Interpretation
-
·
Book investments changed
Investment / intangible book value 84.96m NOK → 145.97m NOK. Reported fact